For nearly one-third of the 3 million adults in the United States living with epilepsy, medications fail to control seizures.

A study published in Brain Communications highlights a new approach to treating drug-resistant epilepsy. Researchers at Mayo Clinic have developed an innovative deep brain stimulation (DBS) platform ...

Epilepsy affects about 50 million people worldwide, making it one of the most common neurological disorders. In India, nearly ...

Information gathered in just one cubic millimeter of a rodent’s cerebral cortex will help unravel the complex neural networks ...

Dawn Kenny undergoes Laser Interstitial Thermal Therapy surgery for epilepsy at The Alfred, led by neurosurgeon Dr Mathew ...

Just before Harmoni Jones turned four years old, her preschool teacher alerted Harmoni’s mother, Deantonecia Jones, that the ...

Neurona will kick start a Phase III trial in H2 2025 investigating NRTX-1001 in patients with a type of drug-resistant ...

Time critical medicines are those prescribed for existing conditions, such as insulin for diabetes, Parkinson’s drugs and ...

Results from Lundbeck's open-label portion of the Pacific trial saw bexicaserin able to elicit seizure reduction in treatment ...

A study published in Brain Communications highlights a new approach to treating drug-resistant epilepsy. Researchers at Mayo Clinic have developed an innovative deep brain stimulation (DBS) platform ...